Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 95Leukemia 94Leukemia, Myeloid, Acute 85Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma 61Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 49Leukemia, Myeloid, Chronic-Phase 48Hodgkin Disease 48Myeloproliferative Disorders 47Multiple Myeloma 45Leukemia, Myeloid, Accelerated Phase 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, B-Cell, Marginal Zone 41Congenital Abnormalities 40Burkitt Lymphoma 40Lymphoma, Large-Cell, Immunoblastic 35Neoplasms, Plasma Cell 34Graft vs Host Disease 32Blast Crisis 32Leukemia, Myelomonocytic, Chronic 30Anemia, Refractory, with Excess of Blasts 29Primary Myelofibrosis 28Dendritic Cell Sarcoma, Interdigitating 28Recurrence 26Myelodysplastic-Myeloproliferative Diseases 26Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Antilymphocyte Serum × Other hematologic neoplasm × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡